Edition:
United Kingdom

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

83.37USD
20 Mar 2019
Change (% chg)

-- (--)
Prev Close
$83.37
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
133,946
52-wk High
$104.82
52-wk Low
$45.15

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 1.03 -1.826
Sep '18 1.10 -1.656
Jun '18 41.44 -0.617
Mar '18 0.95 -1.294
FY 2017 Dec '17 1.63 -1.225
Sep '17 8.07 -0.964
Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 6 1.98 5.00 1.00 2.71
Quarter Ending Jun-19 6 1.98 5.00 1.00 2.71
Year Ending Dec-19 6 8.51 20.00 2.00 10.80
Year Ending Dec-20 8 62.65 260.20 7.00 55.47
Earnings (per share)
Quarter Ending Mar-19 7 -1.90 -1.63 -2.16 -1.27
Quarter Ending Jun-19 7 -1.94 -1.67 -2.21 -1.33
Year Ending Dec-19 7 -8.07 -7.57 -9.34 -5.76
Year Ending Dec-20 8 -7.70 -3.44 -9.41 -5.58
LT Growth Rate (%) 1 34.00 34.00 34.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.32 32.54
P/E High - Last 5 Yrs. -- 147.72 48.15
P/E Low - Last 5 Yrs. -- 47.95 23.42
Beta -- 1.08 0.87
Price to Sales (TTM) 101.33 49.53 8.39
Price to Book (MRQ) 6.92 10.19 5.27
Price to Tangible Book (MRQ) 6.93 13.77 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.74 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.70
Payout Ratio(TTM) -- 7.01 39.60

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago 16.37 48.72 8.02
Sales - 5 Yr. Growth Rate -- 22.78 10.85
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 75.14 47.68
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 11.98 10.47
Capital Spending - 5 Yr. Growth Rate -- 9.12 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) 13.07 3.50 2.98
LT Debt to Equity (MRQ) 0.18 19.49 11.35
Total Debt to Equity (MRQ) 0.71 32.17 16.02
Interest Coverage (TTM) -103.52 -43.13 28.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.25 52.41
Gross Margin - 5 Yr. Avg. -- 60.45 50.39
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -110.47 12.43
Operating Margin (TTM) -394.04 -185.04 5.77
Operating Margin - 5 Yr. Avg. -- -126.95 8.02
Pre-Tax Margin (TTM) -388.91 -175.74 4.80
Pre-Tax Margin - 5 Yr. Avg. -- -132.74 8.31
Net Profit Margin (TTM) -388.91 -182.46 1.53
Net Profit Margin - 5 Yr. Avg. -- -137.13 4.72
Effective Tax Rate (TTM) -- 22.47 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 7,655,517 820,340,930
Net Income/Employee (TTM) -938,547 513,851 92,858,387
Receivable Turnover (TTM) 7.96 6.23 5.82
Inventory Turnover (TTM) -- 1.89 3.41
Asset Turnover (TTM) 0.08 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 6.36 10.60
Return on Assets - 5 Yr. Avg. -- 5.46 11.78
Return on Investment (TTM) -34.88 8.89 13.82
Return on Investment - 5 Yr. Avg. -- 6.77 15.32
Return on Equity (TTM) -40.89 10.00 15.25
Return on Equity - 5 Yr. Avg. -- 8.29 16.41
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 99 99
13 Week 24.13 18.08 99 95
26 Week 48.03 36.78 99 98
52 Week 147.42 109.71 99 71
YTD 136.22 107.45 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 238
Total Shares Held: 46,208,080
3 Mo. Net Change: 1,299,588
# New Positions: 19
# Closed Positions: 42
# Increased Positions: 95
# Reduced Positions: 119
# Net Buyers: -24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.